Expression of thymidine phosphorylase in epithelial ovarian cancer: Correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity

Gynecologic Oncology

Volumn 77, Issue 1, 2000, Pages 26-34

  Hata, Kohkichi ^a   Fujiwaki, Ritsuto ^a   Maede, Yoshinobu ^a   Nakayama, Kentaro ^a,b   Fukumoto, Manabu ^b   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; FEMALE; HUMAN; HUMAN TISSUE; LAPAROTOMY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSVAGINAL ECHOGRAPHY; TUMOR VASCULARIZATION;

EID: 0034051028     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5651     Document Type: Article

References (32)

1. Folkman J, Watson K, Ingber D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61.
2. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 3:1992;65-71.
3. Reynolds K, Farzaneh F, Collins W P, Campbell S, Bourne T H, Lawton F, Moghaddam A, Harris A L, Bicknell R. Association of ovarian cancer malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst. 86:1994;1234-1238.
4. Hata K, Hata T, Collins W P. Association of thymidine phosphorylase concentration with ultrasound-derived indices of blood flow in ovarian masses. Cancer. 80:1997;1079-1084.
5. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Yamada Y. Angiogenic factor. Nature. 356:1992;668.
6. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry. 31:1992;12141-12146.
7. Hata K, Nagami H, Iida K, Miyazaki K, Collins W P. Expression of thymidine phosphorylase in malignant ovarian tumors: correlation with microvessel density and an ultrasound-derived index of angiogenesis. Ultrasound Obstet Gynecol. 12:1998;201-206.
8. Hata K, Kamikawa T, Arao S, Tashiro H, Katabuchi H, Okamura H, Fujiwaki R, Miyazaki K, Fukumoto M. Expression of the thymidine phosphorylase gene in epithelial ovarian cancer. Br J Cancer. 79:1999;1848-1854.
9. Takebayashi Y, Akiyama S, Tani A, Haraguchi M, Furukawa T, Miyadera K, Yamada Y, Aikou T. Induction of thymidine phosphorylase by hypoxia and relationship between expression of thymidine phosphorylase and apoptosis. Proc Annu Am Assoc Cancer Res. 38:1997;48.
10. Ueda M, Ueki K, Kumagai K, Terai Y, Okamoto Y, Ueki, Otsuki Y. Apoptosis and tumor angiogenesis in cervical cancer after preoperative chemotherapy. Cancer Res. 58:1998;2343-2346.
11. Serov S F, Scully R E, Sobin L H. International Histological Classification of Tumors No. 9, Histological Typing of Ovarian Tumors. 1973;World Health Organization, Geneva.
12. Am J Obstet Gynecol. 156:1987;263-264.
13. Hata K, Hata T, Kitao M. Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy. Am J Obstet Gynecol. 172:1995;1496-1500.
14. Nishida M, Hino A, Mori K, Matsumoto T, Tanaka T, Ishitsuka H. Cloning of hybridomas producing anti-human thymidine phosphorylase (dThdPase) and establishment ELISA for measuring dThdPase. J Jpn Soc Cancer. 29:1994;1192.
15. Maeda K, Kang S-M, Ogawa M, Onoda N, Sawada T, Nakata B, Kato Y, Chung Y-S, Sowa M. Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer. 74:1997;545-550.
16. Fox S B, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter K C, Harris A L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissue: an immunohistochemical study. J Pathol. 176:1995;180-190.
17. Weidner N, Semple J P, Welch W R, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
18. Lu C, Tanigawa N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res. 57:1997;221-224.
19. Satake S, Kuzuya M, Ramos M A, Kanda S, Iguchi A. Angiogenic stimuli are essential for survival of vascular endothelial cells in three-dimensional collagen lattice. Biochem Biophys Res Commun. 224:1998;642-646.
20. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1994;1157-1164.
21. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy T L, Centrella M, Madri J A. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest. 97:1996;1436-1446.
22. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S. Angiogenic activity of enzymes. Nature. 368:1994;198.
23. Ishikawa F, Miyadera K, Hellman U, Drexler H, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin C-H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 338:1989;557-562.
24. Moghaddam A, Zhang H-A, Fan T-D, Hu D-E, Lees V C, Turley H, Fox S B, Gatter K C, Harris A L, Bicknell R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA. 92:1995;998-1002.
25. Wohlhueter R M, Marz R, Plagemann P G. Thymidine transport in cultureed mammalian cells: kinetic analysis, temperature dependence and specificity of the transport system. Biochim Biophys Acta. 553:1979;262-283.
26. Stevenson D P, Milligan S R, Collins W P. Effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am J Pathol. 153:1998;1641-1646.
27. O'Dwyer P J, King S A, Hoth D F, Leyland-Jones B. Role of thymidine in biochemical modulation: a review. Cancer Res. 47:1987;3911-3919.
28. Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y, Ishitsuka H. Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull. 31:1983;175-178.
29. Patterson A V, Zhang H, Moghaddam A, Bickell R, Talbot D C, Stratford I J, Harris A L. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer. 72:1995;669-675.
30. Chu E, Lai G-M, Zinn S, Allegra C J. Resistance of a human ovarian cancer line to 5-fluorouracil in DNA. Mol Pharmacol. 38:1990;410-417.
31. Stevenson D P, Milligan S R, Collins W P, Hata K, Miyazaki K. Thymidine phosphrylase activity and prodrug effects in a three-dimensional model of angiogenesis. Am J Pathol. 153:1998;1573-1578.
32. Berne M, Gustavsson B, Almersjo O, Spears P, Sundstrom E. Inhibition of thymidylate synthase after administration of doxifluridine in a transplantable colon carcinoma in the rat. Cancer Invest. 6:1988;377-383.